HCA Healthcare, Inc. (HCA) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
Total Cash From Operating Activities Chart for HCA Healthcare, Inc.
HCA Healthcare, Inc. (HCA) operating cash flow for FY2025 was USD 12.6B, a 20.2% change from FY2024. HCA Healthcare, Inc.'s operating cash flow grew from USD 14.0M in 1990 to USD 12.6B in 2025 (90157.1% over 35 years). Operating cash flow compound annual growth rate: 5-year CAGR of 6.5%, 10-year CAGR of 10.3%, 20-year CAGR of 7.2%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $88.53B
- Implied Share Price
- $408.89
- Enterprise Value
- $137.70B
- Revenue (TTM)
- $78.01B
- EBITDA
- $15.75B
- Profit Margin
- 8.77%
- Trailing P/E
- 13.73
- Forward P/E
- 13.48
- Price/Book (MRQ)
- 291.34
- Price/Sales (TTM)
- 1.16
- EV/EBITDA
- 8.68
- EV/Revenue
- 1.77
- Dividend Yield
- 0.73%
- Book Value
- $-29.81
- Free Cash Flow (FY2025)
- $7.69B
- Free Cash Flow Yield
- 8.69%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.